AMN Stock Recent News
AMN LATEST HEADLINES
DALLAS, June 19, 2024 (GLOBE NEWSWIRE) -- Allied health professionals such as radiology technologists and therapists can generate millions of dollars a year for their facilities, according to a new report from AMN Healthcare, the nation's leading provider of healthcare workforce solutions. The company's 2024 Allied Healthcare Professional Revenue and ROI Report tracks net revenue generated by various types of radiology technologists and therapists, less the cost of staffing them on a contingent basis.
AMN, ARCB and ARW have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2023.
DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- ShiftWise Flex, a next-gen vendor neutral vendor management system (VMS) that serves as a comprehensive workforce management platform for healthcare organizations, announces the launch of Market Insights, a live market intelligence report integrated into the platform.
There are good reasons to believe AMN Healthcare can resume its impressive business performance once the post-pandemic reset in its core market comes to an end. There are several long-term fundamental value drivers over the next decade if the company can execute. The near-term picture remains murky, but insider buying suggests the stock might not have much further to fall. It could offer an attractive risk/reward at these levels.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $2.49 per share a year ago.
Get a deeper insight into the potential performance of AMN Healthcare (AMN) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
AFCG, AAGIY and AMN have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2023.